Navigation Links
34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research
Date:12/6/2009

SEATTLE, Dec. 6 /PRNewswire/ -- A challenge donation from the Bezos family at Saturday's Hutch Holiday Gala boosted the evening's fundraising total to more than $7 million for Fred Hutchinson Cancer Research Center.

"Help the Hutch," a portion of the live auction during which guests raise their bid cards for specific contribution levels, brought in $6.4 million to be directed toward the Hutchinson Center's work to harness the human immune system to battle cancer.

The black-tie Gala took place Dec. 5 from 6 p.m. to midnight at the Seattle Sheraton Hotel. The Bezos family asked for unity to advance and broaden the Center's program in immunotherapy to fight solid-tumor cancers.

In November the family pledged $10 million to the Hutchinson Center to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages. The family chose to structure the gift as a challenge in the hope that it will unite others in the community to join the cause. The three-year challenge period kicked off during Saturday's Gala and will extend through Dec. 31, 2012.

Through the years the Center has led the development of immunotherapy, via bone marrow and stem cell transplantation, to help patients win the battle against leukemia and other blood cancers. These advancements greatly enhanced researchers' understanding of the body's ability to use antibodies, T cells and other immune-system components to fight disease. As a result of their successes, Center scientists believe they are uniquely poised to apply knowledge of the immune system to combat common cancers such as breast, prostate, colon, kidney, ovarian and skin cancer.

Recent discoveries in the Center's Clinical Research Division herald a new era in cancer treatment. An example is the work of Cassian Yee, M.D., who found that infusing patients with their own "helper" T cells could put advanced melanoma into remission. Yee and other Center researchers are now expanding clinical trials that use T cell therapy to treat advanced tumors.

"We are fortunate that our guests know the power of private support in the fight against cancer," Yee said. "Proceeds from tonight's Gala challenge and auction will help us advance all we've done in the lab - moving it into the clinic to help patients," he said.

Gala patrons also bid on exclusive auction packages including a trip to the Big Apple for the Tony Awards, $11,000.; a trip to French Polynesia to view a total solar eclipse, $14,000.; and an exclusive private tasting and dinner for 12 at Long Shadows and Corliss wineries in Walla Walla, $22,000.

The grand finale was the "Diamond Dash" - a raffle for a 30 second shopping spree at Alvin Goldfarb Jeweler's store in downtown Seattle. Sue Hansen held the winning ticket and, strapping on a new pair of Nike Flex running shoes donated for the occasion, ran for a pair of diamond-and-peridot drop earrings. "Diamond Dash" raffle ticket sales raised $30,600.

Presented by the Grace Heffernan Arnold Guild and the Hutch Holiday Gala Board of Directors, the Hutch Holiday Gala featured live and silent auctions, an elegant dinner and entertainment with 700 in attendance. Through the years the Gala has raised more than $62 million in support of key research initiatives and patient programs at the Hutchinson Center.

To learn more, visit the Hutch Holiday Gala Web page at www.fhcrc.org/gala and the Hutchinson Center Web site at www.fhcrc.org.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit www.fhcrc.org.


CONTACT:
Christi Ball Loso
206-667-5215
closo@fhcrc.org

SOURCE Fred Hutchinson Cancer Research Center


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
2. NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
3. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
4. Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
5. Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference
6. Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
7. Spherix Announces Results of Annual Shareholders Meeting
8. Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting
9. Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
10. Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
11. Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):